GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aptabio Therapeutics Inc (XKRX:293780) » Definitions » Other Long Term Assets

Aptabio Therapeutics (XKRX:293780) Other Long Term Assets : ₩36,400 Mil (As of Mar. 2025)


View and export this data going back to 2019. Start your Free Trial

What is Aptabio Therapeutics Other Long Term Assets?

Aptabio Therapeutics's other long-term assets for the quarter that ended in Mar. 2025 was ₩36,400 Mil.

Aptabio Therapeutics's quarterly other long-term assets increased from Sep. 2024 (₩34,984 Mil) to Dec. 2024 (₩37,497 Mil) but then stayed the same from Dec. 2024 (₩37,497 Mil) to Mar. 2025 (₩36,400 Mil).

Aptabio Therapeutics's annual other long-term assets increased from Dec. 2022 (₩29,809 Mil) to Dec. 2023 (₩29,854 Mil) and increased from Dec. 2023 (₩29,854 Mil) to Dec. 2024 (₩37,497 Mil).

Aptabio Therapeutics Other Long Term Assets Historical Data

The historical data trend for Aptabio Therapeutics's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aptabio Therapeutics Other Long Term Assets Chart

Aptabio Therapeutics Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Long Term Assets
Get a 7-Day Free Trial 26,762.89 36,269.64 29,808.53 29,854.49 37,497.16

Aptabio Therapeutics Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 29,637.39 26,243.90 34,984.41 37,497.16 36,399.55

Aptabio Therapeutics Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Aptabio Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aptabio Therapeutics Inc (XKRX:293780) » Definitions » Other Long Term Assets
Comparable Companies
XKRX:092040 XKRX:293480 XKRX:000520 XKRX:008490 XKRX:016580 XKRX:000020 XKRX:234080 XKRX:102460 XKRX:271980 XKRX:023910 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ HKSE:03692 NSE:DIVISLAB XTAE:TEVA
Traded in Other Exchanges
N/A
Address
13, Heungdeok 1-ro, Giheung-gu, Tower 504, Gyeonggi-do, Yongin-Si, KOR, 16954
Website
http://www.aptabio.com
Aptabio Therapeutics Inc is a South Korean pharmaceutical company involved in discovery and development of selective inhibitors of the NOX family of enzymes and aptamer-based anti-cancer drugs. The product portfolio of the company include Lipofector-Q, Plusfector, Lipofector-EXT, Lipofector-2000, Lipofector-EZ and Lipofector-pMAX.

Aptabio Therapeutics Headlines

No Headlines